Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Enhabit, Inc ( (EHAB) ) has issued an update.
On August 6, 2025, Enhabit, Inc. announced that its President and CEO, Barbara A. Jacobsmeyer, will step down by July 31, 2026, or earlier upon the appointment of a successor. The company has initiated a leadership succession plan, retaining Russell Reynolds Associates to assist in the search for a new CEO. Jacobsmeyer will transition to a non-executive advisor role if a successor is appointed before her departure. Additionally, Enhabit has granted retention awards to several key officers to ensure leadership stability during this transition period.
The most recent analyst rating on (EHAB) stock is a Buy with a $9.50 price target. To see the full list of analyst forecasts on Enhabit, Inc stock, see the EHAB Stock Forecast page.
Spark’s Take on EHAB Stock
According to Spark, TipRanks’ AI Analyst, EHAB is a Neutral.
The overall stock score is driven by significant financial challenges and bearish technical indicators. While there are positive signs from recent earnings and corporate events, poor valuation and operational issues weigh heavily on the stock’s attractiveness.
To see Spark’s full report on EHAB stock, click here.
More about Enhabit, Inc
Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national provider of home health and hospice services, operating across 249 home health locations and 114 hospice locations in 34 states. The company focuses on delivering high-quality, compassionate care to patients in their homes, leveraging advanced technology and a dedicated team of clinicians.
Average Trading Volume: 618,636
Technical Sentiment Signal: Sell
Current Market Cap: $338.8M
Learn more about EHAB stock on TipRanks’ Stock Analysis page.